| Demonica Chong, OTD, OTR/L | |
|
1930 E Southern Ave, Tempe, AZ 85282-7518 | |
| (480) 456-0719 | |
| Not Available |
| Full Name | Demonica Chong |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1930 E Southern Ave, Tempe, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831558782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 6399 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Demonica Chong, OTD, OTR/L 1930 E Southern Ave, Tempe, AZ 85282-7518 Ph: () - | Demonica Chong, OTD, OTR/L 1930 E Southern Ave, Tempe, AZ 85282-7518 Ph: (480) 456-0719 |
News Archive
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
The Indiana Federation of Ambulatory Surgical Centers (IFASC) has signed a new sole-source agreement with Amerinet Inc., a leading national healthcare group purchasing organization (GPO).
Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
› Verified 7 days ago
Ms. Susan L Fetter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 W Lodge Dr, Tempe, AZ 85283 Phone: 480-730-4103 Fax: 480-897-0014 | |
Angela Holly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Southern Ave, 310, Tempe, AZ 85282 Phone: 602-567-9881 | |
Ms. Kelly Dunn Will, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 548 E Laguna Dr, Tempe, AZ 85282 Phone: 480-620-4226 | |
Mrs. Rachel Ann Jackson Belanger, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3311 S Holbrook Ln, Tempe, AZ 85282 Phone: 480-518-4602 | |
Cheryl Ray, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3205 S Rural Rd, Tempe, AZ 85282 Phone: 480-730-7100 | |
Lilian Quizon Manaloto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1640 E Verlea Dr, Tempe, AZ 85282 Phone: 602-300-8955 | |
Megan Flesner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1761 E Warner Rd Ste B1, Tempe, AZ 85284 Phone: 480-882-4934 |